GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

A retrospective study reveals the COVID-19 pandemic significantly reduced the frequency of common ophthalmic procedures, ...

Dr. Shimmura explained that this therapy offers two major benefits: it reduces inflammation and promotes healing at the same ...